The newly validated cosmetic ingredients include Emulium Mellifera MB, Compritol 888 CG MB, Emulium Delta MB, Plurol Diisostearique CG and LAS MB, all produced to the same quality, regulatory and analytical standards as Gattefossé's worldwide manufacturing network.
Gattefosse
Gattefossé has validated eight strategic ingredients—including five cosmetic ingredients and three pharmaceutical excipients—at its Lufkin, Texas manufacturing facility, advancing its North American production strategy.
The milestone confirms manufacturing equivalency with the company's global sites and supports regional supply chain resilience through domestic production.
The newly validated cosmetic ingredients include Emulium Mellifera MB, Compritol 888 CG MB, Emulium Delta MB, Plurol Diisostearique CG and LAS MB, all produced to the same quality, regulatory and analytical standards as Gattefossé's worldwide manufacturing network.
